Cardio Vascular Pharmacology

Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.

This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

Dysfunction of the vascular endothelium is thus a hallmark of human diseases. In this review the main endothelial abnormalities found in various human diseases such as cancer, diabetes mellitus, atherosclerosis, and viral infections are addressed.

This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.

  • Pharmacology of drugs affecting vascular tone and blood pressure
  • Role of drugs in coronary circulation
  • Drugs and the electrical conduction of the heart
  • Drugs and the failing heart
  • Pharmacology of the Vascular endothelium

Related Conference of Cardio Vascular Pharmacology

Cardio Vascular Pharmacology Conference Speakers